Neogenomics (NEO) Operating Margin Growth (1y) (2011 - 2026)

Neogenomics (NEO) Operating Margin Growth (1y) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn 50.00
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn 519.00
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn 136.00
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn 376.00
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn -101.00
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn 235.00
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn 93.00
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn 352.00
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn -78.00
10 Neogenomics 2.05 Bn 1.90 Bn 91.88 Mn 2,142.00

Historic Data

Download Data
DateValue
Jun 30, 2026 2,142.00
Mar 31, 2026 679.00
Dec 31, 2025 364.00
Sep 30, 2025 -175.00
Jun 30, 2025 -1,293.00
Mar 31, 2025 301.00
Dec 31, 2024 124.00
Sep 30, 2024 329.00
Jun 30, 2024 701.00
Mar 31, 2024 600.00
Dec 31, 2023 708.00
Sep 30, 2023 1,476.00
Jun 30, 2023 1,140.00
Mar 31, 2023 1,884.00
Dec 31, 2022 1,404.00
Sep 30, 2022 205.00
Jun 30, 2022 -1,337.00
Mar 31, 2022 -3,133.00
Dec 31, 2021 -3,746.00
Sep 30, 2021 -3,645.00